Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: An international multidisciplinary consensus

Basit Öğe Kaydı
dc.authorid0000-0002-6308-1763
dc.contributor.authorLebastchi, Amir H.
dc.contributor.authorGeorge, Arvin Koruthu
dc.contributor.authorPolascik, Thomas J.
dc.contributor.authorColeman, Jonathan
dc.contributor.authorde la Rosette, Jean J. M. C. H.
dc.contributor.authorTürkbey, Barış
dc.contributor.authorWood, Bradford J.
dc.contributor.authorGorin, Michael A.
dc.contributor.authorSidana, Abhinav
dc.contributor.authorGhai, Sangeet
dc.contributor.authorTay, Kae Jack
dc.contributor.authorWard, John
dc.contributor.authorSanchez-Salas, Rafael
dc.contributor.authorMuller, Berrend G.
dc.contributor.authorMalavaud, Bernard
dc.contributor.authorMozer, Pierre
dc.contributor.authorCrouzet, Sebastien
dc.contributor.authorChoyke, Peter L.
dc.contributor.authorUkimura, Osamu
dc.contributor.authorRastinehad, Ardeshir R.
dc.contributor.authorPinto, Peter A.
dc.date.accessioned2020-09-03T08:39:12Z
dc.date.available2020-09-03T08:39:12Z
dc.date.issued2020
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı
dc.description.abstractBackground: Focal therapy (FT) and partial gland ablation (PGA) are quickly adopted by urologists and radiologists as an option for the management of localized prostate cancer.Objective: To find consensus on a standardized nomenclature and to define a follow-up guideline after FT and PGA for localized prostate cancer in clinical practice.Design, setting, and participants: A review of the literature identified controversial topics in the field of FT. Online questionnaires were distributed to experts during three rounds, with the goal to achieve consensus on debated topics. The consensus project was concluded with a face-to-face meeting in which final conclusions were formulated. Outcome measurements and statistical analysis: Controlled feedback of responses of previous rounds were summarized and returned to the participants allowing them to re-evaluate their decisions. The level of agreement to achieve consensus on a topic was set at 80%.Results and limitations: Sixty-five experts participated in this interdisciplinary consensus study (72% urologists; 28% radiologists). The experts propose the use of the herein standardized nomenclature for ablative procedures. After FT/PGA, the following tests should be performed to assess treatment outcomes: prostate-specific antigen (PSA), imaging, biopsies, and functional outcome assessment. Although not a reliable marker for treatment failure, PSA should be measured every 3 mo in the 1st year and every 6 mo thereafter. Magnetic resonance imaging is the preferred image modality and should be performed at 6 and 18 mo after treatment. A systematic 12-core transrectal ultrasoundguided biopsy combined with a targeted biopsy of the treated area should be performed 6-12 mo after treatment. Functional outcomes should be obtained 3-6 mo after treatment for the first time and until stability is attained.Conclusions: The panel recommends the use of the proposed nomenclature and follow-up protocols to generate reliable data supporting a broader implementation of FT as a standard of care for select patients with localized prostate cancer. Patient summary: In this report, we present expert opinion on the use of a standardized nomenclature, and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer.
dc.identifier.citationLebastchi, A. H., George, A. K., Polascik, T. J., Coleman, J., de la Rosette, J. J. M. C. H., Türkbey, B. ... Pinto, P. A. (2020). Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: An international multidisciplinary consensus. European Urology, 78(3), 371-378. https://dx.doi.org/10.1016/j.eururo.2020.05.018
dc.identifier.doi10.1016/j.eururo.2020.05.018
dc.identifier.endpage378
dc.identifier.issn0302-2838
dc.identifier.issn1873-7560
dc.identifier.issue3
dc.identifier.scopusqualityQ1
dc.identifier.startpage371
dc.identifier.urihttps://dx.doi.org/10.1016/j.eururo.2020.05.018
dc.identifier.urihttps://hdl.handle.net/20.500.12511/5769
dc.identifier.volume78
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofEuropean Urologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectFocal Therapy
dc.subjectPartial Gland Ablation
dc.subjectNomenclature
dc.subjectSurveillance
dc.titleStandardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: An international multidisciplinary consensus
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
de la Rosette, Jean-2020.pdf
Boyut:
1.23 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu